Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

In 2025, everyone enrolled in Part D will have their annual out-of-pocket drug costs capped at $2,000. In future years, that cap will rise in step with the rate of change in Part D costs.

On World Alzheimer's Day, we examine how a timely diagnosis can prepare someone with early dementia, and the pros and cons of ...

A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription ...

A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...

Developing advanced drug screening tools is crucial for the advancement of personalized medicine and the creation of more effective treatments. One organ receiving particular attention in this area is ...

Unless officials take action to develop new medications, drug-resistant infections could kill nearly 2 million people a year ...